American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

Handelsman, Yehuda, Henry, Robert R., Bloomgarden, Zachary T., Dagogo-Jack, Sam, DeFronzo, Ralph A., Einhorn, Daniel, Ferrannini, Ele, Fonseca, Vivian A., Garber, Alan J., Grunberger, George, LeRoith, Derek, Umpierrez, Guillermo E., Weir, Matthew R.·2016·Endocrine Practice

DOI 10.4158/ep161292.ps

Cited by (359)

Items 101–200 of 359

Statin Intolerance: A Review and Update
Yumiko Tsushima, Betül Hatipoğlu · 2023 · Endocrine Practice
SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes
Annabelle G Hayes, Lisa Mary Raven, Alexander Viardot, Eugene Kotlyar, Jerry Richard Greenfield · 2023 · Diabetes Care
Management of Diabetes in Patients Undergoing Bariatric Surgery
Christopher M. Mulla, Harris M. Baloch, Samar Hafida · 2019 · Current Diabetes Reports
Efficacy and Safety of SGLT2 Inhibitors in Patients with Type 1 Diabetes: A Meta-analysis of Randomized Controlled Trials
Yingying Yang, Hui Pan, Bo Wang, Shi Chen, Huijuan Zhu · 2017 · Chinese Medical Sciences Journal
Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
Iqra Iqbal, Mohsin Hamid, Muhammad Atique Alam Khan, Aleesha Kainat, Shafaq Tariq · 2019 · Cureus
A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet
Brenda Dorcely, Juliana Nitis, Arthur Z. Schwartzbard, Jonathan D. Newman, Ira J. Goldberg, Melissa Sum · 2020 · Current Diabetes Reviews
Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment
Erasmia Sampani, Pantelis A. Sarafidis, Aikaterini A. Papagianni · 2020 · Expert Opinion on Drug Safety
A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery
Deborah A. Osafehinti, Olivia Okoli, Jocelyne Georges Karam · 2020 · AACE Clinical Case Reports
From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
Andrijana Koceva, Nika Aleksandra Kravos Tramšek · 2024 · Journal of Personalized Medicine
SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review
Henri Y. Lu, Hortense Lu, Christophe Kosinski, Anne Wojtusciszyn, Anne Zanchi, Pierre‐Nicolas Carron, Martín Müller, Philippe Meyer, Jehan Martin, Olivier Müller et al. · 2021 · Journal of Clinical Medicine
SGLT2 Inhibitor–Associated Ketoacidosis vs Type 1 Diabetes–Associated Ketoacidosis
Mahesh Michael Umapathysivam, Bethany Morgan, Joshua M. Inglis, Emily Jane Meyer, Danny Liew, Venkatesan Thiruvenkatarajan, David R. Jesudason · 2024 · JAMA Network Open
Considerations for Initiating a Sodium-Glucose Co-Transporter 2 Inhibitor in Adults With Type 2 Diabetes Using Insulin
Vincent C. Woo, Lori Berard, HARPREET SINGH BAJAJ, Jean-Marie Ékoé, Peter Alexander Senior · 2017 · Canadian Journal of Diabetes
New Diabetic Medication Sodium-Glucose Cotransporter-2 Inhibitors Can Induce Euglycemic Ketoacidosis and Mimic Surgical Diseases: A Case Report and Review of Literature
Antonia-Therese Kietaibl, Peter Fasching, Karl S. Glaser, Alexander H. Petter‐Puchner · 2022 · Frontiers in Surgery
Clinical Characteristics and Outcomes of Diabetic Ketoacidosis in Patients With Type 2 Diabetes using SGLT2 Inhibitors
Raya A. Almazrouei, Bachar O. Afandi, Fatima AlKindi, Romona Devi Govender, Saif Al-Shamsi · 2023 · Clinical Medicine Insights Endocrinology and Diabetes
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
John E. Anderson, Eugene E. Wright, Charles F. Shaefer · 2016 · Diabetes Therapy
Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues
Marta Hernández, Dı́dac Mauricio · 2020 · Advances in experimental medicine and biology
Sodium Glucose Cotransporter 2 and Dipeptidyl Peptidase-4 Inhibition: Promise of a Dynamic Duo
Ildiko Lingvay · 2017 · Endocrine Practice
Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients
Jae‐Seung Yun, Kyuho Kim, Yu‐Bae Ahn, Kyungdo Han, Seung‐Hyun Ko · 2024 · Diabetes & Metabolism Journal
When Guidelines Fail: Euglycemic Diabetic Ketoacidosis After Bariatric Surgery in a Patient Taking a Sodium–Glucose Cotransporter-2 Inhibitor: A Case Report
Sophia Lane, David Paskar, Shatha Hamed, Alberto Goffi · 2018 · A&A Practice
Considerations for SGLT2 inhibitor use in post-transplantation diabetes
Manfred Hecking, Trond Geir Jenssen · 2019 · Nature Reviews Nephrology
The Good, the Bad, and the Ugly: Sodium–Glucose Cotransporter-2 Inhibitors (Gliflozins) and Perioperative Diabetes
Ross K. Kerridge, Ian M. Whyte, F.N. Prior, J. Luu, David Story · 2018 · Anaesthesia and Intensive Care
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms
Ronald Goldenberg, Jeremy D. Gilbert, Robyn L. Houlden, Tayyab Khan, Sapna Makhija, C. David Mazer, Jill Trinacty, Subodh Verma · 2025 · Current Medical Research and Opinion
Canagliflozin-Induced Diabetic Ketoacidosis
Jessica Turner, Tahmina Begum, Roger D. Smalligan · 2016 · Journal of Investigative Medicine High Impact Case Reports
Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis
Chen, Mao-Bing, Xu, Rui-Jun, Zheng, Qi-Han, Zheng, Xu-Wen, Wang, Hua · 2020 · Medicine
Sodium glucose cotransporter 2 inhibitor‐induced ketoacidosis is unlikely in patients without diabetes
Lisa Mary Raven, Christopher Alan Muir, Jerry Richard Greenfield · 2023 · The Medical Journal of Australia
Diabetic Ketoacidosis In Patients With Type 2 Diabetes Recently Commenced On SGLT-2 Inhibitors: An Ongoing Concern
Mohamed Ahmed, Malachi J. McKenna, Rachel Katherine Crowley · 2017 · Endocrine Practice
Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis
Kiyoung Lee, Ie Byung Park, Seung Hee Yu, Soo‐Kyung Kim, So Hun Kim, Da Hea Seo, Seongbin Hong, Ja Young Jeon, Dae Jung Kim, Soo Wan Kim et al. · 2019 · Diabetes Metabolic Syndrome and Obesity
Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2‐inhibitor therapy
Gregory P. Westcott, Alissa R. Segal, Joanna Mitri, Florence M. Brown · 2020 · Endocrinology Diabetes & Metabolism
Positionspapier: Operation und Diabetes mellitus (Update 2023)
Antonia-Therese Kietaibl, Joakim Huber, Martin Clodi, Heidemarie Abrahamian, Bernhard H. Ludvik, Peter Fasching · 2023 · Wiener klinische Wochenschrift
Incidence of sodium–glucose cotransporter-2 inhibitor-associated perioperative ketoacidosis in surgical patients: a prospective cohort study
Hiroyuki Seki, Norifumi Kuratani, Toshiya Shiga, Yudai Iwasaki, Kanae Karita, Kazuki Yasuda, Natsuko Yamamoto, Yuko Nakanishi, Kenji Shigematsu, Kensuke Kobayashi et al. · 2024 · Journal of Anesthesia
Euglycemic Diabetic Ketoacidosis
Hsiao-Hui Ju · 2024 · Critical Care Nursing Clinics of North America
OP449 inhibits breast cancer growth without adverse metabolic effects
Gadi Shlomai, Zara Zelenko, Irini Markella Antoniou, Marilyn Stasinopoulos, Aviva Tobin‐Hess, Michael Peter Vitek, Derek LeRoith, Emily J. Gallagher · 2017 · Endocrine Related Cancer
Therapeutic augmentation of ketogenic diet with a sodium-glucose cotransporter 2 inhibitor in a super-refractory status epilepticus patient
Joseph R. Blunck, Joseph W. Newman, Ronald K. Fields, John E. Croom · 2018 · Epilepsy & Behavior Case Reports
Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Eugênio Cersósimo, John M. Miles · 2018 · Current Diabetes Reviews
A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus
Nishant Garodia, K.M. PRASANNA KUMAR, Sujoy Ghosh, William J. Canovatchel, Sujith Tumkur Rajashekar · 2016 · Indian Journal of Endocrinology and Metabolism
Ketoacidosis due to a Low-carbohydrate Diet in an Elderly Woman with Dementia and Abnormal Eating Behavior
Hitoshi Iwata, Seiichiro Tsuzuki, Mitsunaga Iwata, Teruhiko Terasawa · 2017 · Internal Medicine
Systematic literature review and network meta‐analysis of sodium‐glucose co‐transporter inhibitors vs metformin as add‐on to insulin in type 1 diabetes
Bryony Langford, Marc Evans, Tao Haskins‐Coulter, Molly O'Connor, Harriet E. O. Cant, Lucy A. Eddowes, Christopher Edmonds, Amarjeet Tank · 2019 · Diabetes Obesity and Metabolism
Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature
Qasim Zafar Iqbal, Danil Mishiyev, Zeeshan Zia, Raffaele A Ruggiero, Ghulam Mustafa Aftab · 2020 · Cureus
Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy
Melissa‐Rosina Pasqua, Michael A. Tsoukas, Ahmad Haidar · 2021 · Journal of Diabetes Science and Technology
SGLT-2 Inhibitors: Proliferating Indications and Perioperative Pitfalls
Jai Madhok, Matthew W. Vanneman · 2022 · Journal of Cardiothoracic and Vascular Anesthesia
A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium–Glucose Cotransporter 2 Inhibitor
Paola Andrea Sanchez Garay, Gabriela Zúñiga, Robert Lichtenberg · 2020 · Clinical Diabetes
Multicentre prospective observational study of sodium-glucose cotransporter-2 inhibitor-associated postoperative ketoacidosis: the SAPKA study protocol
Hiroyuki Seki, Norifumi Kuratani, Toshiya Shiga, Yudai Iwasaki, Kanae Karita, Kazuki Yasuda, Tomoko Yorozu · 2021 · BMJ Open
Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis
Julia Selwyn, Ariana R Pichardo-Lowden · 2023 · Diabetology
Euglycaemic diabetic ketoacidosis in bariatric surgery patients with type 2 diabetes taking canagliflozin
Christoffel Johannes Van Niekerk, James R. Wallace, Mark C. Takata, Roger C. Yu · 2018 · BMJ Case Reports
Management of diabetic ketoacidosis
Bruno Adler Maccagnan Pinheiro Besen, Otavio Ranzani, Mervyn Singer · 2022 · Intensive Care Medicine
Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets
Caroline G. P. Roberts, Shaminie J. Athinarayanan, Robert E. Ratner, Guillermo E. Umpierrez · 2025 · Diabetes Obesity and Metabolism
Diabetes: the place of new therapies
Ketan Dhatariya · 2018 · Therapeutic Advances in Endocrinology and Metabolism
Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study
Pilar Vich-Pérez, Juan Carlos Abánades-Herranz, Gustavo Mora Navarro, Ángela Carrasco-Sayalero, Miguel Ángel Salinero-Fort, Ignacio Sevilla-Machuca, Mar Sanz-Pascual, Cristina Álvarez-Hernández-Cañizares, Carmen de Burgos‐Lunar · 2023 · PLoS ONE
Dapagliflozin Use in Children with Advanced Heart Failure Undergoing Heart Transplantation: A Matched Case-Control Study
David M. Newland, Yuk M. Law, Erin L. Albers, Reda Ali, Joshua M. Friedland‐Little, Christina Hartje‐Dunn, Mariska S. Kemna, Lisa R. Knorr, Thomas L. Nemeth, Kathryn L. Spencer et al. · 2024 · Pediatric Cardiology
Diabetic ketoacidosis in patients treated with SGLT2 inhibitors: experience at a tertiary hospital
Labrini Papanastasiou, Spyridoula Glycofridi, Christos Gravvanis, Nikitas Skarakis, Irene Papadimitriou, Georgia Kanti, Chara Kapsali, Theodora Kounadi · 2020 · HORMONES
Sodium–Glucose Cotransporter-2 Inhibitor–associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery
Ahsen Chaudhry, Craig Roels, Julie Lee · 2022 · Canadian Journal of Diabetes
Risk factors of dapagliflozin-associated diabetic ketosis/ketoacidosis in patients with type 2 diabetes mellitus: A matched case-control study
Zinan Zhao, Fei Zhao, Yatong Zhang, Xin Yang Hu, Jianchun Li, Chao Tian, Pengfei Jin, Deping Liu · 2023 · Diabetes Research and Clinical Practice
Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial)
Mohammad Shafi Kuchay, Pushpender Khatana, Mitali Mishra, Parvathi Surendran, Parjeet Kaur, Jasjeet Singh Wasir, Harmandeep Kaur Gill, Apanshu Singh, Rujul Jain, Chhavi Kohli et al. · 2023 · Acta Diabetologica
Population‐based incidence of diabetic ketoacidosis in type 2 diabetes: medical claims data analysis in Japan
Masato Takeuchi, Taichi Kawamura, Izumi Sato, Koji Kawakami · 2017 · Pharmacoepidemiology and Drug Safety
Prolonged diabetic ketoacidosis associated with canagliflozin
GORDON P. SLOAN, Tania Kakoudaki, Nishant Ranjan · 2018 · Endocrinology Diabetes and Metabolism Case Reports
Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy
Eleni Papadokostaki, Evangelos N. Liberopoulos · 2019 · Case Reports in Endocrinology
Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier’s gangrene
Patrick J. Lindsay, Lauren E. Gibson, Edward A. Bittner, Sheri M. Berg, Marvin G. Chang · 2020 · International Journal of Surgery Case Reports
Re-emergence of a forgotten diabetes complication
Murat Dağdeviren, Tolga Akkan, Derun Taner Ertuğrul · 2024 · Turkish Journal of Emergency Medicine
Use of SGLT2 inhibitors after bariatric/metabolic surgery: Risk/benefit balance
André Jacques Scheen · 2023 · Diabetes & Metabolism
Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes
Paola Fioretto, Angelo Avogaro · 2017 · Expert Opinion on Pharmacotherapy
Incretins: B eyond type 2 diabetes
Paresh Dandona, Husam Ghanim, Ajay Chaudhuri · 2018 · Diabetes Obesity and Metabolism
Sodium–Glucose Cotransporter 2 Inhibitor–Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review
Ahmad Yehya, Archana Sadhu · 2019 · Clinical Diabetes
Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery
João Paulo Jordão Pontes, Caroline Souto de Melo, Flávia Bittar Britto Arantes, Juan Thomaz Gabriel de Souza Ramos, Norma Sueli Pinheiro Módolo, Laís Helena Navarro e Lima · 2021 · Journal of Clinical Anesthesia
Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
Huan Ju Yu, Vincent C. Woo · 2017 · Diabetes Metabolic Syndrome and Obesity
Cardiovascular Safety of Antihyperglycemic Agents: “Do Good or Do No Harm”
Antonis S. Manolis, Theodora A. Manolis, Antonis S. Manolis · 2018 · Drugs
Practical aspects of initiation and use of SGLT2 inhibitors: inpatient and outpatient perspectives
В. В. Салухов, Gagik Radikovich Galstyan, Т. A. Ilyinskaya · 2022 · Diabetes Mellitus
From starvation to time-restricted eating: a review of fasting physiology
Candida Joan Rebello, Dachuan Zhang, Joseph C. Anderson, Rebecca F. Bowman, Pamela M. Peeke, Frank L. Greenway · 2024 · International Journal of Obesity
Missed postoperative metabolic acidosis associated with sodium-glucose transporter 2 inhibitors in cardiac surgery patients: a retrospective analysis
Hyeon A Kim, Joo Yeon Kim, Young Hwan Kim, Young Tak Lee, Pyo Won Park · 2024 · Scientific Reports
Association of British Clinical Diabetologists (ABCD) position statement on the risk of diabetic ketoacidosis associated with the use of sodium-glucose cotransporter-2 inhibitors
Umesh Kumar Dashora, Alison Gallagher, Ketan Dhatariya, Peter H. Winocour, Rob Gregory · 2016 · British Journal of Diabetes
SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
Vishnu Vardhan Garla, Javed Butler, Lillian F. Lien · 2021 · Current Cardiology Reports
Severe Prolonged SGLT2i-induced Euglycemic Diabetic Ketoacidosis Refractory to Standard Therapy and Dialysis: Case Report and Literature Review
Raya A. Almazrouei, Fatima AlKindi, Aisha M Al-Shamsi, Tasnim Heider Dawoud, Ahmad Chaaban, Masood ur Rahman · 2021 · Oman Medical Journal
Seguridad de los iSGLT-2. Revisión de las reacciones adversas notificadas a nivel nacional
Óscar Esteban‐Jiménez, Cristina Navarro Pemán, L. Urieta-González · 2017 · Medicina de Familia SEMERGEN
The ketogenic diet is not for everyone: contraindications, side effects, and drug interactions
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, Dorota Łojko, Hanna Karakuła‐Juchnowicz, Georgia Ede, Żaneta Grzywacz, Katarzyna Antosik, Shebani Sethi, David Unwin · 2026 · Annals of Medicine
Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report
Brian Vadasz, Mattan Arazi, Yousef Shukha, Ofir Koren, Riad Taher · 2021 · Journal of Medical Case Reports
The use of SGLT2 inhibitors in older people: What is important?
Giuseppe Armentaro, Raffaele Maio, Leonardo Bencivenga, Chukwuma Okoye, Giandomenico Severini, Velia Cassano, Valeria Zanobbi, Valentino Condoleo, Giuseppe Bellelli, Giuseppe Rengo et al. · 2025 · Aging Clinical and Experimental Research
Post-Operative Euglycemic Diabetic Ketoacidosis in a Patient With SGLT-2 Inhibitor Use and Recent Sleeve Gastrectomy
Alexander Martin Smith, John Holtrop, Moutamn Sadoun · 2021 · Cureus
Type 2 Diabetes Mellitus
Adrian Po Zhu Li, Dulmini Kariyawasam · 2021 · Elsevier eBooks
A Case of Septic Shock Due to Serratia marcescens Pyelonephritis and Bacteremia in a Patient Receiving Empagliflozin
Wesley D. Kufel, Ali Scrimenti, Jeffrey M. Steele · 2016 · Journal of Pharmacy Practice
Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” in Perioperative Hospital Management
Christopher Mackintosh, Arti Tewari, Jason L. Siegel, R Doris Wang, William Freeman · 2019 · The Neurohospitalist
Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis
Clara I. Gomez-Sanchez, Bian Wu, Jeffrey E. Gotts, Robert W. Chang · 2021 · Journal of Vascular Surgery Cases and Innovative Techniques
Empagliflozin induced euglycemic diabetic ketoacidosis in a patient undergoing coronary artery bypass graft despite discontinuation of the drug 48 hours prior to the surgery
Mohammad Shafi Kuchay, Sunil Kumar Mishra, Yatin B. Mehta · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER study
Jennifer Ngan, Yee Wen Kong, Jenna Goad, Michael Huang, Alicia Josephine Jenkins, Sara Vogrin, Steven L. Trawley, Adele Manzoney, Miyuki Nakano, Elif Ilhan Ekinci et al. · 2025 · BMJ Open
The ketogenic diet: history, mechanism of action, indications and contraindications
Е. В. Иванникова, Marina V. Altashina, Ekaterina Anatol'evna Troshina · 2021 · Problems of Endocrinology
Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
Daniele Sartori, Jeffrey K Aronson, Igho Onakpoya · 2020 · Systematic Reviews
Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series
Henrique Alencastro Puls, Nathan L. Haas, Brian J. Franklin, Nik Theyyunni, Carrie E. Harvey · 2021 · The American Journal of Emergency Medicine
Preoperative Evaluation and Care of Heart Transplant Candidates
Nian Chih Hwang, Cumaraswamy Sivathasan · 2022 · Journal of Cardiothoracic and Vascular Anesthesia
Cetosis normoglicémica en adolescente con diabetes tipo 1 recibiendo insulina y dapaglifozina: Reporte de un caso
Marcia Alejandra Pereyra Álvarez, Cristhian Felipe Ramírez, Rossana Román · 2017 · Revista chilena de pediatría
SGLT-2 Inhibitors—a Culprit of Diabetic Ketoacidosis Postbariatric Surgery
Qasim Zafar Iqbal, Danil Mishiyev, Muhammad Niazi, Zeeshan Zia, Saud Bin Abdul Sattar, Abdullah Jahanghir, Shahed Quyyumi · 2020 · Case Reports in Critical Care
Euglycemic Diabetic Ketoacidosis (EDKA) in a Patient Receiving Dapagliflozin
Sher Muhammad Sethi · 2021 · Acta Endocrinologica (Bucharest)
Clinical insights into management options for recurrent type 2 diabetes and cardiovascular risk after metabolic-bariatric surgery
Roberta Lupoli, Erminia Lembo, Annalisa Giosuè, Luigi Schiavo, Brunella Capaldo · 2022 · Nutrition Metabolism and Cardiovascular Diseases
Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
Fernanda Moura Victor, Sérgio Ricardo de Lima Andrade, Francisco Alfredo Farias Bandeira · 2022 · Springer eBooks
Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports
Waleed M. Altowayan · 2022 · Annals of Medicine and Surgery
Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia
Benjamin Cohen, Yael Harris, Rifka Schulman‐Rosenbaum · 2023 · Endocrine Practice
Euglycemic Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy
Ryan B. Dull, Mikayla L. Spangler, Emily L. Knezevich, Britney M. Lau · 2017 · Journal of Pharmacy Practice
Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use
Erica A. Amianda, Thomas S. Gavigan, Toghrul Talishinskiy, Douglas R. Ewing, Hans J. Schmidt · 2021 · Obesity Surgery
Perioperative Management of Blood Glucose in Adults with Diabetes Mellitus
Ally Wang, Ji Ae Yoon, Niloofar Mirsaidi, Rifka Schulman‐Rosenbaum · 2023 · Contemporary Endocrinology
Comment on Rubino et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016;39:861–877
Jens Aberle, Burkhard Göke · 2016 · Diabetes Care
[Risk of euglycemic diabetic ketoacidosis due to low-carbohydrate diet while taking empagliflozin: a case report]
Yamamoto, Mariko, Ide, Naohito, Kitajima, Shinzo, Obayashi, Masakazu, Asada, Kei, Matsushima, Satoru, Ito, Masaharu · 2019 · YAKUGAKU ZASSHI
Chronic treatment with SGLT-2 inhibitors is associated with ICU admission and disease severity in patients with diabetic ketoacidosis: a propensity score–matched cohort study
Fernando Sebastián‐Valles, María Sara Tapia-Sanchiz, Víctor Navas-Moreno, Marta Lopez-Ruano, Carmen Martínez-Otero, Elena Carrillo-López, Carolina Sager La Ganga, Juan José Raposo‐López, Selma Amar, Sara González Castañar et al. · 2024 · Internal and Emergency Medicine
SGLT-2 inhibitor induced Euglycemic diabetes ketoacidosis in post laparoscopic distal pancreatectomy: A case report
Chi-Chi Chen, Ting-Yuan Feng, Shengchun Wang, Tzu-Hong Chen, Shao-Jiun Chou, Hsiang-Chun Jan · 2025 · International Journal of Surgery Case Reports